• The intellectual property assets of Accellta include a portfolio of patents pertaining to novel techniques and products, including:
    • Pluripotent stem Cell culturing
    • Human foreskin-derived feeder cells
    • Growth media for feeder-free culturing of hPSC
    • Stem Cell expansion in suspension
    • Stem Cell culturing as single-cells in bioreactors
    • Stem-Cell controlled differentiation
    • Medium formulation